Pfizer CEO: ‘China will be my major competition by 2030’
Albert Bourla’s comments come a month after the Chinese government unveiled a five-year biomedical plan to grow its pharma exports.
Albert Bourla’s comments come a month after the Chinese government unveiled a five-year biomedical plan to grow its pharma exports.
Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Australia starts investigation into OpenAI Medicare breach
How DFE Pharma supports confident continuous manufacturing decisions
Industry partnership will determine the success of the transition to low-GWP pMDIs